| Оңтүстік Корея | Түркия | Австрия | |
| Протонды-сәулелік терапия | бастап $22,000 | бастап $70,000 | бастап $80,000 |
| Краниотомия | бастап $16,500 | бастап $5,650 | бастап $20,000 |
| Кибер-пышақ | бастап $11,500 | бастап $4,750 | бастап $50,000 |
| Гамма-пышақ | бастап $13,500 | бастап $6,300 | бастап $32,000 |
| Томотерапия | - | бастап $12,000 | бастап $30,000 |
Сіз Bookimed қызметтері үшін төлемейсіз. ми рагының емдеудің бағалары клиниканың баға тізіміне сәйкес келеді. Сіз жеткенде тікелей клиникада төлейсіз. Бөліктермен төлеу қолжетімді.
Bookimed Сіздің қауіпсіздігіңізді қамтамасыз етеді. Біз тек ми рагының жүргізу үшін жоғары халықаралық стандарттарға сәйкес келетін клиникалармен ғана жұмыс істейміз. Олардың бүкіл әлем бойынша халықаралық науқастарға қызмет көрсету үшін қажетті лицензиялары бар.
Bookimed тегін көмек және қолдау ұсынады. Жеке медициналық координатор сапарға дейін, кезінде және кейін Сізбен байланыста. ми рагының емдеу кезінде Сіз басқа елде жалғыз қалмайсыз.
Оңтүстік Кореяның нейрохирургия саласындағы жетекші ауруханаларының бірі болып табылатын Самсунг медициналық орталығында эндоскопиялық оталар жасауға және ми ісіктерін алып тастауға маманданған.
South Korea reports a 44.1% 5-year survival rate for malignant brain cancer, surpassing many Western averages. Procedures for benign brain tumors achieve a 95% success rate for optimal removal. Leading centers in Seoul utilize multidisciplinary management to ensure precise surgical and radiological outcomes.
Bookimed Expert Insight: Success in South Korea is driven by extreme specialization and patient volume. Asan Medical Center alone performs over 65,000 annual operations. This high frequency allows surgeons like Dr. Do Hyun Nam at Samsung Medical Center to maintain elite proficiency in complex endoscopic and robotic techniques. Choosing these high-volume tertiary hospitals significantly correlates with lower reoperation rates within 1 year.
Patient Consensus: Patients note that Korean neurosurgical centers are exceptionally fast and efficient with surgery scheduling. While clinical success is high, families emphasize that recovery often involves navigating post-operative speech or rehabilitation needs.
South Korea offers extensive advanced radiation and non-invasive brain cancer treatments. JCI-accredited centers utilize Proton Beam Therapy and Carbon-Ion technology. Facilities like Samsung Medical Center provide Gamma Knife and CyberKnife radiosurgery. These precise methods target tumors while protecting healthy brain tissue.
Bookimed Expert Insight: South Korea is a world leader in digital oncology integration. Seoul National University Bundang Hospital achieved complete digitalization in 2004. This allows for seamless coordination between MRI scans and radiation planning. Patients benefit from exceptionally fast treatment transitions in these smart hospital environments.
Patient Consensus: Patients note that non-invasive radiation is frequently offered as a primary alternative to surgery. They emphasize the importance of bringing all MRI records to ensure doctors can accurately assess if radiation alone is feasible.
Samsung Medical Center, Seoul National University Hospital, and Asan Medical Center are the top facilities for brain cancer treatment in South Korea. These JCI-accredited institutions utilize Gamma Knife and proton therapy. They maintain high surgical volumes and specialized multidisciplinary neuro-oncology teams in Seoul.
Bookimed Expert Insight: While patients often choose the Big 4 hospitals in Seoul, Samsung Medical Center and Asan Medical Center stand out for their massive scale. These centers treat over 2,000,000 and 180,000 patients annually. This volume allows them to maintain specialized teams for rare tumor types that smaller clinics see less frequently.
Patient Consensus: Patients emphasize starting evaluations at major Seoul academic centers to access specific neuro-oncology teams. They note that specialized international clinics are essential for managing language support and navigating complex treatment plans.
International patients typically stay in South Korea for 3 to 4 weeks for brain cancer surgery. This duration ensures intracranial pressure stabilizes before air travel. The process includes 1 to 2 days of diagnostics followed by 5 to 13 days of inpatient hospitalization.
Bookimed Expert Insight: Korea's infrastructure supports extremely high surgical volumes, with Asan Medical Center performing over 65,000 operations annually. Patients can leverage this efficiency by completing pre-op PET/CT and contrast MRI within 48 hours. Digitalized facilities like Seoul National University Bundang Hospital often expedite pathology results, potentially shortening the total stay.
Patient Consensus: Patients note that while the hospital stay is brief, post-surgical fatigue and headaches make staying near the clinic essential. Coordination with home-country oncologists for follow-up radiation can significantly reduce the time spent abroad.
South Korean hospitals manage language barriers through professional medical interpreters and dedicated international patient coordinators. Recovery support includes translated discharge instructions and specialized nursing care. Facilities like Severance Hospital and Samsung Medical Center hold Joint Commission International (JCI) accreditation, ensuring global communication and safety standards for brain cancer treatment.
Bookimed Expert Insight: While large centers like Samsung Medical Center serve over 2 million patients annually, the highest quality support is found in their specialized International Healthcare Centers. These departments bypass general hospital staffing to provide dedicated English-speaking coordinators. This is critical for brain surgery recovery, as neurosurgical patients often experience fatigue or temporary cognitive changes that make standard communication difficult.
Patient Consensus: Patients emphasize the need for a dedicated caregiver during the first weeks after brain surgery. Professional interpreters are vital during discharge to explain complex medication schedules for steroids and anti-seizure drugs.